DLL3 — Delta-Like 3

DLL3 — Delta-Like 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLL3</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta-Like 3</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[27197](https://www.ncbi.nlm.nih.gov/gene/27197)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[604579](https://www.omim.org/entry/604579)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000090932</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Delta-like protein 3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Spondylocostal Dysostosis, Neurodevelopmental Disorders, [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

DLL3 encodes Delta-like protein 3, a membrane-bound ligand for [Notch receptors](/mechanisms/notch-signaling-pathway) that plays crucial roles in embryonic neurodevelopment, somite segmentation, and boundary formation in the nervous system. Unlike other DLL family members, DLL3 has unique inhibitory functions in the Notch pathway, primarily localizing to the Golgi apparatus and acting as a negative regulator of Notch signaling[@chiba2008].

DLL3 — Delta-Like 3

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLL3</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLL3</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta-Like 3</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[27197](https://www.ncbi.nlm.nih.gov/gene/27197)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[604579](https://www.omim.org/entry/604579)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000090932</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)</td></tr>
<tr><td><strong>Protein Name</strong></td><td>Delta-like protein 3</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), Spondylocostal Dysostosis, Neurodevelopmental Disorders, [Parkinson's Disease](/diseases/parkinsons-disease)</td></tr>
</table>
</div>

Overview

DLL3 encodes Delta-like protein 3, a membrane-bound ligand for [Notch receptors](/mechanisms/notch-signaling-pathway) that plays crucial roles in embryonic neurodevelopment, somite segmentation, and boundary formation in the nervous system. Unlike other DLL family members, DLL3 has unique inhibitory functions in the Notch pathway, primarily localizing to the Golgi apparatus and acting as a negative regulator of Notch signaling[@chiba2008].

The DLL3 gene is essential for proper somite segmentation during embryonic development and is expressed in the developing nervous system. Recent research has revealed that DLL3 and the Notch pathway are dysregulated in several neurodegenerative diseases, including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease), where they contribute to impaired neurogenesis, neuroinflammation, and neuronal dysfunction[@lavas2019].

Molecular Biology

Gene Structure

The DLL3 gene is located on chromosome 19q13.2 and consists of 8 exons spanning approximately 8 kb. It encodes a type I transmembrane protein of 667 amino acids with a molecular weight of approximately 75 kDa.

Protein Structure

The DLL3 protein contains several characteristic domains:

DSL Domain Function

The DSL domain mediates specific interactions with Notch receptors:

• Notch1: Primary receptor for DLL3
• Notch2: Secondary receptor
• Notch3: Lower affinity interaction

Unusual Cellular Localization

Unlike other Notch ligands, DLL3 exhibits unique localization:

• Golgi Apparatus: Primary location
• Plasma Membrane: Limited presence
• Secretory Vesicles: Some reports

Role in Notch Signaling

Canonical Notch Pathway

The Notch signaling pathway is a conserved cell-cell communication mechanism:

DLL3 as a Notch Inhibitor

DLL3 functions differently from other Notch ligands:

Target Genes

Notch signaling regulates numerous genes:

| Gene Category | Examples | Function |
|---------------|----------|----------|
| Transcription Factors | Hes1, Hey1, Hey2 | Developmental timing |
| Cell Cycle Regulators | Cyclin D1, p21 | Proliferation control |
| Signaling Molecules | Jagged1, DLL1 | Feedback regulation |
| Effector Proteins | Hes5, Dll1 | Notch output |

Role in Neurodevelopment

Somite Segmentation

DLL3 is critical for somite formation during embryogenesis:

Neural Development

DLL3 in the developing nervous system:

Brain Development

• Ventral Telencephalon: NPC maintenance
• Cerebellar Development: Granule cell precursors
• Cortical Neurogenesis: Layer-specific patterning

Role in Neurodegeneration

Alzheimer's Disease

DLL3 dysregulation contributes to AD pathogenesis through multiple mechanisms[@anderson2020]:

• Notch signaling in adult neurogenesis
• Hippocampal NPC dysfunction
• Reduced neuronal production

• Notch interacts with APP processing
• γ-secretase duality (APP vs Notch)
• Aβ effects on Notch signaling

• Notch-tau crosstalk
• Phosphorylation effects
• NFT formation connections

• Notch in synaptic plasticity
• LTP modulation
• Memory consolidation

Parkinson's Disease

In [Parkinson's Disease](/diseases/parkinsons-disease):

• Notch in substantia nigra development
• Developmental vulnerability
• Regeneration potential

• Notch signaling effects on [alpha-synuclein](/proteins/alpha-synuclein)
• Protein aggregation interactions

• Microglial Notch activation
• Inflammatory gene expression

Neuroinflammation

Notch signaling modulates neuroinflammation[@sweeney2021]:

• NF-κB cross-talk
• Cytokine production
• Phagocytosis regulation

• Inflammatory responses
• Reactive gliosis
• Neurotoxicity

• T-cell infiltration
• Adaptive immunity

Expression Patterns

Tissue Distribution

DLL3 expression:

• Embryonic Tissues: Highest during development
• Brain: Neural progenitors, certain neurons
• Somites: Precursor structures
• Low Adult Expression: Most tissues

Brain Region Specificity

• Ventricles: Subventricular zone
• Hippocampus: Dentate gyrus subgranular zone
• Cerebellum: External granule layer
• Cortex: Subpial population

Cellular Localization

• Golgi Apparatus: Primary location
• Plasma Membrane: Limited
• Endoplasmic Reticulum: Some reports

Therapeutic Implications

Targeting Notch-DLL3 in Neurodegeneration

Drug Development Strategies

| Strategy | Approach | Disease |
|----------|----------|---------|
| γ-Secretase Inhibitors | Block Notch cleavage | AD, cancer |
| DLL3 Antibodies | Neutralize DLL3 | SCD, tumors |
| Notch Agonists | Enhance signaling | PD regeneration |
| DLL3 Agonists | Activate Notch | AD neurogenesis |

Clinical Considerations

• Notch pathway complexity
• Multiple receptor-ligand interactions
• Tissue-specific effects
• Developmental toxicity

Interaction Network

Notch Receptors

• [NOTCH1](/proteins/notch1) - Primary receptor
• [NOTCH2](/proteins/notch2) - Secondary receptor
• [NOTCH3](/proteins/notch3) - CNS expression

Other Notch Ligands

• DLL1: Activating ligand
• DLL4: Activating ligand
• JAG1: Activating ligand (Jagged1)
• JAG2: Activating ligand (Jagged2)

Signaling Partners

• NICD: Notch intracellular domain
• CSL/RBPJκ: Transcription factor
• MAML: Co-activator
• HES/HEY: Target transcription factors

DLL3-Specific Interactors

• Fringe Modifiers: OFUT1, LFNG
• Mindbomb: E3 ubiquitin ligase
• NUMB: Negative regulator

Animal Models

Knockout Studies

• DLL3 KO mice: Lethal (severe somite defects)
• Phenotype: Defective segmentation
• Mosaic models: Viable for analysis

Transgenic Models

• DLL3 overexpression: Dominant-negative effects
• DLL3 mutants: Human disease models

Disease Models

• AD models: Notch changes observed
• PD models: DLL3 alterations

Therapeutic Models

• γ-secretase inhibitor: Effects on neurogenesis
• DLL3 antibodies: Preclinical testing

Clinical Significance

Spondylocostal Dysostosis

DLL3 mutations cause autosomal dominant spondylocostal dysostosis (SCD):

• Genetics: Heterozygous DLL3 mutations
• Phenotype: Vertebral segmentation defects
• Inheritance: Autosomal dominant
• Penetrance: Variable expressivity

Biomarker Potential

• DLL3 expression as disease marker
• Notch pathway activation status
• Neurogenesis assessment

Diagnostic Applications

• Disease classification
• Progression monitoring
• Therapeutic targeting

Research Findings

| Year | Finding | Model/Context |
|------|---------|---------------|
| 2000 | DLL3 mutations cause SCD | Human genetics |
| 2004 | DLL3 in somite segmentation | Mouse models |
| 2008 | Notch ligand specificity | Cell biology |
| 2014 | DLL3 in CNS development | Mouse models |
| 2019 | Notch in neurodegeneration | Review |
| 2020 | DLL3-Notch in AD | Human tissue |
| 2022 | Notch modulation in AD | Preclinical |

Disease Mechanisms Summary

Alzheimer's Disease Pathogenesis

DLL3 contributes to AD through:

• Adult NPC function
• Hippocampal plasticity
• Memory formation

• γ-secretase substrate competition
• Aβ effects on Notch
• Signaling impairment

• Microglial activation
• Cytokine production

Parkinson's Disease Pathogenesis

DLL3 involvement in PD:

• Dopaminergic neuron development
• Circuit formation

• Subventricular zone function
• Replacement potential

• Glial Notch signaling

Cross-Links

• [Notch Signaling Pathway](/mechanisms/notch-signaling-pathway)
• [Neurodevelopment](/mechanisms/neurodevelopment)
• [Alzheimer's Disease Mechanisms](/diseases/alzheimers-disease)
• [Parkinson's Disease Mechanisms](/diseases/parkinsons-disease)
• [NOTCH1](/proteins/notch1)
• [NOTCH2](/proteins/notch2)
• [DLL1](/proteins/dll1-protein)
• [Neurogenesis](/mechanisms/adult-neurogenesis)

See Also

• [Genes Index](/genes)
• [Proteins Index](/proteins)
• [Mechanisms Index](/mechanisms)
• [Developmental Pathways](/mechanisms/neurodevelopment)

External Links

• NCBI Gene: [27197](https://www.ncbi.nlm.nih.gov/gene/27197)
• Ensembl: [ENSG00000090932](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000090932)
• UniProt: [Q9NZU6](https://www.uniprot.org/uniprot/Q9NZU6)
• GeneCards: [DLL3](https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLL3)
• OMIM: [604579](https://www.omim.org/entry/604579)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving dll3 discovered through SciDEX knowledge graph analysis:

Pathway Diagram

The following diagram shows the key molecular relationships involving DLL3 — Delta-Like 3 discovered through SciDEX knowledge graph analysis: